Found 3 hits for monomerid = 50215754 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Aurora kinase A
(Homo sapiens (Human)) | BDBM50215754
(4-(2-(3-(6-methoxy-1H-benzo[d]imidazol-2-yl)-1H-py...)Show SMILES COc1ccc2nc([nH]c2c1)-c1n[nH]cc1C=Cc1cncc2ccccc12 |w:17.20| Show InChI InChI=1S/C22H17N5O/c1-28-17-8-9-19-20(10-17)26-22(25-19)21-16(13-24-27-21)7-6-15-12-23-11-14-4-2-3-5-18(14)15/h2-13H,1H3,(H,24,27)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 530 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development L.L.C.
Curated by ChEMBL
| Assay Description Inhibition of aurora-A |
Bioorg Med Chem Lett 17: 4557-61 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.092 BindingDB Entry DOI: 10.7270/Q2DB81JD |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50215754
(4-(2-(3-(6-methoxy-1H-benzo[d]imidazol-2-yl)-1H-py...)Show SMILES COc1ccc2nc([nH]c2c1)-c1n[nH]cc1C=Cc1cncc2ccccc12 |w:17.20| Show InChI InChI=1S/C22H17N5O/c1-28-17-8-9-19-20(10-17)26-22(25-19)21-16(13-24-27-21)7-6-15-12-23-11-14-4-2-3-5-18(14)15/h2-13H,1H3,(H,24,27)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 610 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development L.L.C.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 |
Bioorg Med Chem Lett 17: 4557-61 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.092 BindingDB Entry DOI: 10.7270/Q2DB81JD |
More data for this Ligand-Target Pair | |
Receptor tyrosine-protein kinase erbB-2
(Homo sapiens (Human)) | BDBM50215754
(4-(2-(3-(6-methoxy-1H-benzo[d]imidazol-2-yl)-1H-py...)Show SMILES COc1ccc2nc([nH]c2c1)-c1n[nH]cc1C=Cc1cncc2ccccc12 |w:17.20| Show InChI InChI=1S/C22H17N5O/c1-28-17-8-9-19-20(10-17)26-22(25-19)21-16(13-24-27-21)7-6-15-12-23-11-14-4-2-3-5-18(14)15/h2-13H,1H3,(H,24,27)(H,25,26) | PDB MMDB
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research & Development L.L.C.
Curated by ChEMBL
| Assay Description Inhibition of HER2 |
Bioorg Med Chem Lett 17: 4557-61 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.092 BindingDB Entry DOI: 10.7270/Q2DB81JD |
More data for this Ligand-Target Pair | |